Luliconazole indications and usage: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Luliconazole}} {{CMG}}; {{AE}} {{AZ}} ===Indications and Usage=== LUZU (luliconazole) Cream, 1% is indicated for the topical treatment of interdigital tinea pedi...")
 
No edit summary
 
Line 5: Line 5:
===Indications and Usage===
===Indications and Usage===


LUZU (luliconazole) Cream, 1% is indicated for the topical treatment of interdigital tinea pedis, tinea cruris, and tinea corporis caused by the organisms Trichophyton rubrum and Epidermophyton floccosum, in patients 18 years of age and older.
LUZU (luliconazole) Cream, 1% is indicated for the topical treatment of interdigital tinea pedis, tinea cruris, and tinea corporis caused by the organisms Trichophyton rubrum and Epidermophyton floccosum, in patients 18 years of age and older.<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = LUZU (LULICONAZOLE) CREAM [MEDICIS PHARMACEUTICAL CORP.] | url =http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a7016010-ce43-4c09-8d21-aeb697ffed31 | publisher =  | date =  | accessdate =  }}</ref>
 
<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = LUZU (LULICONAZOLE) CREAM [MEDICIS PHARMACEUTICAL CORP.] | url =http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a7016010-ce43-4c09-8d21-aeb697ffed31 | publisher =  | date =  | accessdate =  }}</ref>


==References==
==References==

Latest revision as of 15:25, 8 January 2014

Luliconazole
LUZU® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Adverse Reactions
Drug Interactions
Dosage and Administration
Clinical Studies
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2]

Indications and Usage

LUZU (luliconazole) Cream, 1% is indicated for the topical treatment of interdigital tinea pedis, tinea cruris, and tinea corporis caused by the organisms Trichophyton rubrum and Epidermophyton floccosum, in patients 18 years of age and older.[1]

References

  1. "LUZU (LULICONAZOLE) CREAM [MEDICIS PHARMACEUTICAL CORP.]".

Adapted from the FDA Package Insert.